FDA Inspection 1096337 — Arensia Exploratory Medicine LLC
The FDA completed an inspection of Arensia Exploratory Medicine LLC on June 13, 2019 in Tbilisi. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Tbilisi (Georgia)
Additional Details
Clinical BA/BE